Effect of Supplemental Lutein and Zeaxanthin on Serum, Macular Pigmentation, and Visual Performance in Patients with Early Age-Related Macular Degeneration
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose. To compare the 2-year effect of multiple doses of lutein/zeaxanthin on serum, macular pigmentation, and visual performance on patients with early age-related macular degeneration (AMD).Methods. In this randomized, double-blinded, and placebo-controlled trial, 112 early AMD patients randomly received either 10 mg lutein, 20 mg lutein, a combination of lutein (10 mg) and zeaxanthin (10 mg), or placebo daily for 2 years. Serum concentration of lutein/zeaxanthin, macular pigment optical density (MPOD), visual functions including best-spectacle corrected visual acuity (BCVA), contrast sensitivity (CS), flash recovery time (FRT), and vision-related quality of life (VFQ25) was quantified.Results. Serum lutein concentration and MPOD significantly increased in all the active treatment groups. Supplementation with 20 mg lutein was the most effective in increasing MPOD and CS at 3 cycles/degree for the first 48 weeks. However, they both significantly increased to the same peak value following supplementation with either 10 mg or 20 mg lutein during the intervention. No statistical changes of BCVA or FRT were observed during the trial.Conclusions. Long-term lutein supplementation could increase serum lutein concentration, MPOD, and visual sensitivities of early AMD patients. 10 mg lutein daily might be an advisable long-term dosage for early AMD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
B IOLOGIC M ECHANISMS OF THE P ROTECTIVE R OLE OF L UTEIN AND Z EAXANTHIN IN THE E YE
Krinsky, N. I., Landrum, J. T., & Bone, R. A. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073307 · Cited by 779
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1484 · Cited by 739
Ma, L., Dou, H.-L., Wu, Y.-Q., Huang, Y.-M., Huang, Y.-B., Xu, X.-R., Zou, Z.-Y., & Lin, X.-M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004260 · Cited by 237
Self-citationAssociations between Lutein, Zeaxanthin, and Age-Related Macular Degeneration: An Overview
Carpentier, S., Knaus, M., & Suh, M. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802066979 · Cited by 182
Cited by
Rodriguez-Concepcion, M., Avalos, J., Bonet, M. L., Boronat, A., Gomez-Gomez, L., Hornero-Mendez, D., Limon, M. C., Meléndez-Martínez, A. J., Olmedilla-Alonso, B., Palou, A., et al. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.04.004 · Cited by 1,031
Bernstein, P. S., Li, B., Vachali, P. P., Gorusupudi, A., Shyam, R., Henriksen, B. S., & Nolan, J. M. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.10.003 · Cited by 545
Evans, J. R., & Lawrenson, J. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000254.pub4 · Cited by 335
Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease
Mrowicka, M., Mrowicki, J., Kucharska, E., & Majsterek, I. (2022) · Nutrients · doi:10.3390/nu14040827 · Cited by 299
The Effect of Lutein on Eye and Extra-Eye Health
Buscemi, S., Corleo, D., Di Pace, F., Petroni, M. L., Satriano, A., & Marchesini, G. (2018) · Nutrients · doi:10.3390/nu10091321 · Cited by 260
“Study (year) Design (Number of Participants) Intervention and Lutein Supplementation Effects AREDS2 (2013) [27] RCT, participants with bilateral drusen or AMD in 1 eye (4176); 4 groups: G1 (1007); G2 (1038); G3 (1062); G4 (1069) G1: AREDS formulation; G2: AREDS + L 10 mg + Z 2 mg; G3: AREDS + DHA 350 mg + EPA 650 mg G…”
BackgroundResultInfluentialBöhm, V., Lietz, G., Olmedilla-Alonso, B., Phelan, D., Reboul, E., Bánati, D., Borel, P., Corte-Real, J., de Lera, A. R., Desmarchelier, C., et al. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuaa008 · Cited by 231
Moran, N. E., Mohn, E. S., Hason, N., Erdman, J. W., & Johnson, E. J. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy025 · Cited by 205
Carotenoids from Haloarchaea and Their Potential in Biotechnology
Rodrigo-Baños, M., Garbayo, I., Vílchez, C., Bonete, M., & Martínez-Espinosa, R. (2015) · Marine Drugs · doi:10.3390/md13095508 · Cited by 183
“(β,ε-carotene-3,3′-diol) [42,58–61], Zeaxanthin (β,β-carotene-3,3′-diol) [38,62,63], and Violaxanthin (5,6:5′,6′-diepoxy-5,5′,6,6′-tetrahydro-β-carotene-3,3′-diol) [64–68].”
Metadata
- Authors
- Huang, Y.-M., Dou, H.-L., Huang, F.-F., Xu, X.-R., Zou, Z.-Y., & Lin, X.-M.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-8
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2089645896
- Cited by
- 78
- References
- 5
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.